• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

New BD syringe manufacturing lines are up and running in Nebraska

October 7, 2021 By Sean Whooley

BDBD (NYSE:BDX) announced today that it increased its manufacturing capacity and domestic supply for syringes and needles.

Franklin Lakes, N.J.-based BD’s new syringe and needle manufacturing lines, which were completed on an accelerated timeline, represent BD’s partnership with Department of Health and Human Services’ (HHS) Assistant Secretary for Preparedness and Response (ASPR).

In July 2020, ASPR’s Biomedical Advanced Research and Development Authority (BARDA) provided $42 million as part of a $70 million project to expand the operations and manufacturing lines at BD’s Holdrege, Nebraska facility.

According to a news release, the new lines mark a manufacturing milestone as the U.S. enters flu vaccination season amid domestic efforts to vaccinate against COVID-19, too. To date, BD has provided several hundred million injection devices to the federal campaign, the company said.

BD previously announced plans to invest $1.2 billion over four years to enhance its manufacturing capacity and technology for pre-fillable syringes and advanced drug delivery systems in addition to its latest ramp-up.

“As the fight against COVID-19 continues, we are steadfast in our commitment to securing the nation’s supply continuity of these critical injection devices,” BD president of medication delivery systems Rick Byrd said in the release. “Our teams are working tirelessly – as they have been since the beginning of the pandemic – to ensure that all of our customers, including the U.S. government, have the supplies they need to vaccinate against this virus while simultaneously managing routine, preventative health care needs, such as the seasonal flu.”

HHS assistant secretary for preparedness and response Dawn O’Connell noted that BD’s domestic production provides a massive boost in the vaccination efforts with lives at stake and immediate need making it difficult to wait for supplies to be shipped from other countries.

“Domestic manufacturing has proven critical to responding rapidly and effectively to this pandemic,” added HHS assistant secretary for preparedness and response Dawn O’Connell. “Taking action now to increase U.S.-based manufacturing capacity will allow us to meet the needs of patients and health care providers while also creating valuable U.S. jobs.”

Filed Under: Auto-injectors, Business/Financial News, Contract Services, Drug-Device Combinations, Featured Tagged With: BARDA, BD, Becton Dickinson, coronavirus, COVID-19, HHS

IN CASE YOU MISSED IT

  • FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent
  • Medtronic completes Intersect ENT acquisition
  • Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes
  • Here’s what’s next for Insulet after the launch of Omnipod 5, CEO change
  • Senseonics beats The Street in Q1 following Eversense E3 launch

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS